Results 291 to 300 of about 9,106,328 (402)
Performance of radiomics analysis in ultrasound imaging for differentiating benign from malignant adnexal masses: A systematic review and meta‐analysis
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.Currently, the IOTA‐ADNEX model and the O‐RADS are the most reliable methods for calculating the risk of malignancy in adnexal masses. However, some skill is required to accurately recognize the ultrasound variables included in these methods. In recent years, several authors have demonstrated that radiomic analysis, which does not rely on expert ...Francesca Moro, Marianna Ciancia, Maria Sciuto, Giulia Baldassari, Huong Elena Tran, Antonella Carcagnì, Anna Fagotti, Antonia Carla Testa +7 morewiley +1 more sourceDefining Excellence: The First Core Set of Quality Indicators for the European Paediatric Surgical Audit on Hirschsprung's Disease Care
Acta Paediatrica, Volume 114, Issue 6, Page 1464-1477, June 2025.ABSTRACT Aim
This study aimed to develop a universally applicable core set of quality indicators for Hirschsprung's disease care through a consensus‐driven process, to standardise and improve care quality across Europe. Methods
A modified Delphi method was used to achieve consensus among healthcare professionals (HPs) and patient representatives (PRs ...Daniel Rossi, Anna Löf Granström, Mikko Pakarinen, Kristin Bjørnland, Ivo de Blaauw, Mark Ellebæk, Francesco Fascetti Leon, Dirk‐Jan Gloudemans, Alessio Pini Prato, Udo Rolle, Nicole Schwarzer, Merit Tabbers, Alejandra Vilanova, Rene Wijnen, Cornelius E. J. Sloots, Tomas Wester, on behalf of the EPSA|ERNICA Registry Group and collaborative authors, R. (Roberto) Tambucci, C. (Charlotte) Vercauteren, P. (Pietro) Bagolan, J. (Jochen) Hubertus, S. (Sabine) Sarnacki, A. (Ann) Neirinck, J. (Jurgita) Gailiene, S. (Stefanie) Maerzheuser, P. (Pernilla) Stenström, P. (Pedro Palazón) Bellver, E. (Eva) Amerstorfer, P. (Piotr) Czauderna, K. (Kim) Vanderlinden, H. (Holger) Till, S. (Stefano) Giuliani, L.E. (Lucas) Matthyssens, V.D. (Vincenzo Davide) Catania, H. (Hendt) Versteegh, C. (Célia) Crétolle, R. (Renate) Fartacek, J. (Jenny) Oddsberg, M. (Maurizio) Cheli, E. (Enrico) Ciardini, K. (Kristine) Hagelsteen, R. (Rony) Sfeir, A. (Anne) Dariel, D. (Dirk) Vervloessem, L. (Louise) Montalva, L. (Lucia) Migliazza, C. (Carmine) Noviello, A. (Annika) Mutanen, B. (Benjamin) Allin, V. (Vojtěch) Dotlačil, G. (Giovanna) Riccipetitoni, M. (Miriam) Duci, M.G. (Maria Grazia) Faticato, M. (Mark) Malota, K. (Krystian) Toczewski, N. (Niels) Qvist, F.V. (Filomena Valentina) Paradiso, S. (Stefano) Avanzini, E. (Elena) Palleri, J. (Julia) Brendel, R. (Riccardo) Guanà, I. (Inge) Ifaoui, W. (Wouter) F.J. Feitz, S. (Simon) Eaton, A. (Anna) Gunnarsdóttir, P. (Paola) Midrio, L. (Laura) Valfre, F. (Francesco) Macchini, X. (Xavier) Tarrado, R. (Roel) Bakx, J. (Judith) Lindert, R. (Riccardo) Coletta, N. (Niels) Bjørn, J. (Joep) Derikx, L. (Leopoldo) Martinez, A.C. (Andreas) Heydweiller, R. (Ruta Vilija) Dagilyte, C. (Can İhsan) Öztorun, M. (Marta) Erculiani, S. (Sebastiaan) Van Cauwenberge, A. (Andrea) Conforti, J. (Johanna) Ludwiczek, M.S. (Maria Sophie) Stockinger, M. (Marc) Miserez, C. (Cigdem Ulukaya) Durakbasa, T. (Tutku) Soyer, A. (Antonio) Di Cesare, C. (Carmen) Capito, V. (Vincenzo) Domenichelli, C. (Clara Massaguer) Bardaji, J.H. (Jan‐Hendrik) Gosemann, I. (Isabelle) Scheers, J. (Jetske) Ruiterkamp, J. (Jørgen Mogens) Thorup, M. (Marieke J.) Witvliet, C. (Conny J.H.M). Meeussen, M. (Maria) Juelsgaard, G. (Gabriele) Gallo, N. (Nadezhda) Tolekova, K. (Konrad) Reinshagen +99 morewiley +1 more sourceRetrospective Cohort Study: Scope for Improvement—Barriers to Post‐Polypectomy Surveillance in the Integrated Technologies for Improved Polyp Surveillance Cohort
Alimentary Pharmacology &Therapeutics, Volume 61, Issue 8, Page 1381-1386, April 2025.Within 6210 bowel screening participants between 2009 and 2016 in NHS Greater Glasgow and Clyde, increasing deprivation (Scottish Index of Multiple Deprivation quintile 1 vs. 5); was associated with non‐surveillance (OR 1.68; p < 0.001), and more metachronous polyps (54.0% vs. 49.3%) and cancer (1.1% vs.Charlotte Mathews, Aleena Nauman, Mark Johnstone, Reiss Stoops, Alexander Tham, Emma C. Parsons, Kathryn A. Robb, William Sloan, Gerard Lynch, Joanne Edwards, Stephen T. McSorley, the INCISE collaborative group +11 morewiley +1 more sourceClinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial
Alimentary Pharmacology &Therapeutics, Volume 61, Issue 8, Page 1276-1289, April 2025.Diets modelled on healthy eating guidelines, but differing in the content of emulsifiers available in the food supply, improved disease activity on sonographic criteria, Harvey‐Bradshaw Index and patient‐reported outcomes over 4 weeks in 24 patients with active Crohn's disease, with no differences according to the content of emulsifiers.Jessica A. Fitzpatrick, Peter R. Gibson, Kirstin M. Taylor, Ellen J. Anderson, Antony B. Friedman, Zaid S. Ardalan, Rebecca L. Smith, Emma P. Halmos +7 morewiley +1 more sourceEnterocolitis associated with glofitamab—First report and clinicopathological findings in three cases
British Journal of Haematology, EarlyView.Summary
Glofitamab is a CD3‐CD20 bispecific antibody used to treat B‐cell non‐Hodgkin lymphoma. We describe three cases of enterocolitis occurring with glofitamab at a single institution. Similarities between cases include onset post cycle 4–5, moderately elevated faecal calprotectin, abnormal bowel avidity on positron emission tomography scan (2/3 ...Sean McKeague, Molly Robertson, Sam van der Linde, Christine Khoo, Jonathan Segal, Sean Harrop, Adrian Minson, Andrew W. Roberts, Michael Dickinson +8 morewiley +1 more source